A randomised double-blind study of the effect of cranberry juice in decreasing the incidence of urinary symptoms and urinary tract infections in patients undergoing pelvic radiotherapy for cancer of bladder or cervix
ISRCTN | ISRCTN44646348 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN44646348 |
Secondary identifying numbers | MI43 |
- Submission date
- 31/08/2005
- Registration date
- 16/09/2005
- Last edited
- 25/09/2012
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Mrs Cathy Hutchison
Scientific
Scientific
North Glasgow University Hospitals NHS Trust
Divisional Offices (West)
Western Infirmary
Dumbarton Road
Glasgow
G11 6NT
United Kingdom
Study information
Study design | Randomised double blind placebo controlled parallel group trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Prevention |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
Scientific title | |
Study objectives | To assess whether drinking cranberry juice decreases the incidence of urinary tract infections and urinary side effects |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Bladder or cervix cancer |
Intervention | Cranberry juice or placebo |
Intervention type | Drug |
Pharmaceutical study type(s) | |
Phase | Not Specified |
Drug / device / biological / vaccine name(s) | Cranberry juice or placebo |
Primary outcome measure | Increase in Common Toxicity Criteria (CTC) grade of urinary tract symptoms OR development of urinary tract infection |
Secondary outcome measures | Other CTC toxicities |
Overall study start date | 24/02/2003 |
Completion date | 01/01/2008 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Sex | Both |
Target number of participants | 250 |
Key inclusion criteria | 1. Patients with cervical cancer about to start standard chemoradiation (weekly cisplatin chemotherapy plus radiation therapy as below) or radiation therapy (4300-4500 cGy over 20 fractions +/-selectron radiotherapy) 2. OR patients with bladder cancer about to commence standard radical radiotherapy (5000-5240 cGy over 20 fractions). 3. Age ≥ 18 years. 4. ECOG performance status ≤ 2. 5. Written informed consent and the ability to comply with the requirements of the study. |
Key exclusion criteria | 1. Pregnant or lactating women are excluded. Female patients of child-bearing potential are eligible provided they have a negative urine pregnancy test prior to enrolment and agree to use approved contraceptive precautions during the trial and for 6 months afterwards. 2. Patients with irritable bowel syndrome (they may experience episodes of diarrhoea as a side effect of drinking cranberry juice). 3. Patients who are diabetic (due to the high sugar content of the juice). 4. Patients who have rheumatoid arthritis (the acidic juices may exacerbate joint pain). 5. Patients with urinary symptoms or urinary tract infections at baseline. 6. Patients receiving antispasmodics or antibiotics for urinary symptoms. 7. Patients with an indwelling urinary catheter. |
Date of first enrolment | 24/02/2003 |
Date of final enrolment | 01/01/2008 |
Locations
Countries of recruitment
- Scotland
- United Kingdom
Study participating centre
North Glasgow University Hospitals NHS Trust
Glasgow
G11 6NT
United Kingdom
G11 6NT
United Kingdom
Sponsor information
Greater Glasgow NHS Board, North Glasgow Division (UK)
Hospital/treatment centre
Hospital/treatment centre
West Research Office
Administration Building
Western Infirmary
Glasgow
G11 6NT
Scotland
United Kingdom
Website | http://www.ngt.org.uk/research/home.htm |
---|---|
https://ror.org/05kdz4d87 |
Funders
Funder type
Charity
Western Endowment Fund (UK)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 01/03/2012 | Yes | No |